Our Research Publications
Updated August 2025
Pagination
- Previous page
- Page 15
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Aubé E, Lewin A, O'Brien SF, Grégoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Seed CR, Camirand Lemyre F, the Surveillance RA, Policy Subgroup of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Blood operators | MSM research |
The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Asamoah-Boaheng M, Goldfarb DM, Karim ME, O’Brien SF, Wall N, Drews SJ, Barakauskas V, Jassem AN, Grunau B | 2022 | J Infect Dis | View The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Researchers | Clinical research |
HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Lambert G, Cox J, Fourmigue A, Dvorakova M, Apelian H, Moodie EEM, Grace D, Skakoon-Sparling S, Moore DM, Lachowsky N, Jollimore J, Lal A, Parlette A, Hart TA | 2022 | Transfusion | View HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Researchers | MSM research |
Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada | Sheffield WP, Bhakta V, Howell A, Jenkins C, Serrano K, Johnson N, Lin Y-CJ, Colwill K, Rathod B, Greenberg B, Gingras A-C, Evans DH, Flaumenhaft E, Beckett A, Drews SJ, Devine DV | 2022 | Transfusion | View Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada | Researchers | Basic research |
Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study | Trépanier P, Fournier D, Simard C, Fontaine MJ, Stroncek D, Takanashi M, McKenna D, Schwartz J, Tanhehco YC, Reems J-A, Torrents S, Kogler G, Liedtke S, Giroux M, Holovati JL, Louis I, Prasath A, Pineault N, Bazin R, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Transfusion | View Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study | Researchers | Benchmarking and standard setting |
Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage | Murru A, Allard M-È, Paré G, Vaillancourt M, Boyer L, Cayer M-P, Vitry J, Landry P, Labrecque M-M, Robitaille N, Branch DR, Girard M, Fernandes MJ | 2022 | Front Med | View Comparison of Neutrophil Function in Granulocyte Concentrates From Prednisone- and G-CSF-Treated Donors: Effect of Stimulant, Leukapheresis and Storage | Researchers | Basic research |
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 | Grunau B, Golding L, Prusinkiewicz MA, Asamoah-Boaheng M, Armour R, Marquez AC, Jassem AN, Barakauskas V, O’Brien SF, Drews SJ, Haig S, Lavoie PM, Goldfarb DM | 2022 | Microbiol Spectr | View Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 | Researchers | Clinical research |
The impact of donor ferritin testing on blood availability in Canada | Blake JT, O'Brien SF, Goldman M | 2022 | Vox Sang | View The impact of donor ferritin testing on blood availability in Canada | Blood operators | New or improved product or process |
Preservation and Storage of Cells for Therapy: Current Applications and Protocols | Acker JP, Bondarovych M, Brunotte R, Buriak IA, Fuller BJ, Glasmacher B, Goltsev AM, Gregor J, Gryshkov O, Herrity K, Honegrová B, Hunt CJ, Jandová M, Johnstone BH, Kilbride P, Lánská M, Mann J, Měřička P, Musall KG, Mutsenko V, Mykhailova O, Petrenko Y, Radocha J, Sherry AM, Stacey GN, Štěrba L, Vokurková D, William N, Woods EJ | 2022 | Cell Engineering and Regeneration | View Preservation and Storage of Cells for Therapy: Current Applications and Protocols | Researchers | Benchmarking and standard setting |
FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services | Bodnar M, Bienz M, Clarke G | 2022 | Blood.ca website | View FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services | Health care providers | New or improved product or process |
Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Health care providers | Benchmarking and standard setting |
Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Patterson S, Sandercock N, Verhovsek M | 2022 | Am J Hematol | View Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Health care providers | Clinical research |
Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Shopsowitz KE, Lim C, Shih AW, Fishbane N, Berry BR, Bigham M, Petraszko T, Trudeau J, Wyatt M, Yan MTS, Morrison D | 2022 | Vox Sang | View Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Blood operators | Benchmarking and standard setting |
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Drews SJ, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Yi Q-L, O’Brien SF, Mostafa HH | 2022 | Microbiol Spectr | View SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Researchers | Clinical research |
Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W, Ning S | 2022 | Guide de la pratique transfusionnelle | View Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies | Holmberg JA, Henry SM, Burnouf T, Devine D, Marschner S, Boothby TC, Burger SR, Chou ST, Custer B, Blumberg N, Siegel DL, Spitalnik SL | 2022 | Transfusion | View National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies | Researchers | Benchmarking and standard setting |
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia | Li N, Mahamad S, Parpia S, Iorio A, Foroutan F, Heddle NM, Hsia CC, Sholzberg M, Rimmer E, Shivakumar S, Sun HL, Refaei M, Hamm C, Arnold DM | 2022 | J Thromb Haemost | View Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia | Researchers | New or improved product or process |
Surveillance report | O'Brien SF | 2022 | Blood.ca website | View Surveillance report | Blood operators | Benchmarking and standard setting |
Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex | Sask KN, Thong B, Goodarzynejad N, Berry LR, Chan AKC | 2022 | Biointerphases | View Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex | Researchers | Basic research |
GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach | Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, Traversy G, Akl EA, Mayer M, Schünemann HJ, Guyatt GH | 2022 | J Clin Epidemiol | View GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach | Researchers | Clinical research |
Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Iba T, Levy JH, Warkentin TE | 2022 | Crit Care Med | View Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Benchmarking and standard setting |
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination | Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, Abe KT, Wang JH, Pasculescu A, Maltseva M, Rocheleau L, Pelchat M, Fazel-Zarandi M, Iskilova M, Barrios-Rodiles M, Bennett L, Yau K, Cholette F, Mesa C, Li AX, Paterson A, Hladunewich MA, Goodwin PJ, Wrana JL, Drews SJ, Mubareka S, McGeer AJ, Kim J, Langlois M-A, Gingras A-C, Durocher Y | 2022 | medRxiv | View A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination | Researchers | New or improved product or process |
The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients | Alshalani A, van Manen L, Boshuizen M, van Bruggen R, Acker JP, Juffermans NP | 2022 | Transfus Med Hemother | View The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients | Researchers | Clinical research |
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure | Candeliere J, Kirkham AM, Shorr R, Morris G, Berardi P, Seftel MD, Allan DS | 2022 | Cell Ther Transplant | View Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure | Health care providers | New or improved product or process |
Investigation of Acute Transfusion Reactions | Leary H, Webert KE, Heddle NM | 2022 | Practical Transfusion Medicine | View Investigation of Acute Transfusion Reactions | Health care providers | Benchmarking and standard setting |
Database-driven research and big data analytic approaches in transfusion medicine | Ning S, Li N, Barty R, Arnold D, Heddle NM | 2022 | Transfusion | View Database-driven research and big data analytic approaches in transfusion medicine | Researchers | Clinical research |
A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion | Qadri SM, Liu Y, Barty RL, Heddle NM, Sheffield WP | 2022 | Vox Sang | View A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion | Researchers | Clinical research |
Concentré de recherche: Évaluation de la sécurité des pompes à perfusion pour les transfusions de globules rouges | Wolfe A | 2022 | Blood.ca website | View Concentré de recherche: Évaluation de la sécurité des pompes à perfusion pour les transfusions de globules rouges | Researchers | Benchmarking and standard setting |
Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Thompson T, Callum J | 2022 | Ontario Regional Blood Coordinating Network February 2022 Newsletter | View Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Health care providers | Clinical research |
Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study | Razatos A, Acker JP, de Korte D, Bégué S, Noorman F, Doyle B, Zia M, Min K, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study | Researchers | New or improved product or process |
International Forum on the Management of Major Haemorrhage: Responses | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Responses | Health care providers | Benchmarking and standard setting |
International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018 | Crowder LA, Wendel S, Bloch EM, O'Brien SF, Delage G, Sauleda S, Leiby DA, for the WP-TTID Subgroup on Parasites | 2022 | Vox Sang | View International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018 | Researchers | Benchmarking and standard setting |
(NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus | Almizraq RJ, Frias Boligan K, Loriamini M, McKerlie C, Branch DR | 2022 | Front Immunol | View (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus | Researchers | Basic research |
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH | 2022 | Blood Adv | View Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes | Walsh G | 2022 | Blood.ca website | View Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes | Regulators | MSM research |
Circular of information for the use of human blood components: Whole Blood | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Whole Blood | Health care providers | Benchmarking and standard setting |
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study | Kuter DJ, Rogers KA, Boxer MA, Choi M, Agajanian R, Arnold DM, Broome CM, Field JJ, Murakhovskaya I, Numerof R, Tong S | 2022 | Am J Hematol | View Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study | Researchers | Clinical research |
Blood Collection Agency Messaging to Donors and the Public in Canada and Australia During the Early Days of COVID-19 | Haw J, Thorpe R, Holloway K | 2022 | Front Commun | View Blood Collection Agency Messaging to Donors and the Public in Canada and Australia During the Early Days of COVID-19 | Blood operators | Ethical, legal and social implications research |
An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype | Floch A, Vege S, Berardi P, Hannon J, Ochoa-Garay G, Lomas-Francis C, Westhoff CM | 2022 | Transfusion | View An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype | Researchers | Clinical research |
International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Cardigan R, New HV, Estcourt L, Zhiburt E, Dubey R, Bengtsson J, Jöud M, Castillo C, Cid J, Lozano M, Gounder D, Flanagan P, Morley S, Clarke G, Devine D, Hindawi S, AlOtaibi A, Bub CB, Kutner JM, Ikeda T, Goto N, Okazaki H, Fontaine MJ, Pasion J, Song L, Latham T, Kerkhoffs JL, de Haas M, Zwaginga JJ, Gathof BS, Ommer K, Pirenne F, Raba M, Francois A, Daly J, Powley T, Dunbar N | 2022 | Vox Sang | View International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Health care providers | Benchmarking and standard setting |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Alshalani A, Uhel F, Cremer OL, Schultz MJ, de Vooght KMK, van Bruggen R, Acker JP, Juffermans NP | 2022 | Blood Adv | View Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Researchers | Clinical research |
Novel platelet products including cold-stored platelets | Devine DV | 2022 | Hematology | View Novel platelet products including cold-stored platelets | Health care providers | New or improved product or process |
Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Jacquot C, Tiberghien P, van den Hurk K, Ziman A, Shaz B, Apelseth TO, Goldman M, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Researchers | Benchmarking and standard setting |
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ | 2022 | Viruses | View SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | Researchers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Holloway K, Simms N, Hayeems RZ, Miller FA | 2022 | Hastings Cent Rep | View The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Regulators | Ethical, legal and social implications research |
Complement contributions to COVID-19 | Conway EM, Pryzdial ELG | 2022 | Curr Opin Hematol | View Complement contributions to COVID-19 | Researchers | Basic research |
Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Hahn B, Quee F, Prinsze FJ, Gregoire Y, O'Brien SF, Germain M, van de Laar T, Zaaijer HL, van den Hurk K | 2022 | Transfusion | View Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Blood operators | MSM research |